Published in Drug Discov Today on October 31, 2013
Investigation of the novel lead of melanocortin 1 receptor for pigmentary disorders. Evid Based Complement Alternat Med (2014) 0.86
Drug design of cyclin-dependent kinase 2 inhibitor for melanoma from traditional Chinese medicine. Biomed Res Int (2014) 0.85
In silico design for adenosine monophosphate-activated protein kinase agonist from traditional chinese medicine for treatment of metabolic syndromes. Evid Based Complement Alternat Med (2014) 0.81
Potential retinoid x receptor agonists for treating Alzheimer's disease from traditional chinese medicine. Evid Based Complement Alternat Med (2014) 0.80
Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptor. Biomed Res Int (2014) 0.79
Potential Protein Phosphatase 2A Agents from Traditional Chinese Medicine against Cancer. Evid Based Complement Alternat Med (2014) 0.78
Computational design of apolipoprotein E4 inhibitors for Alzheimer's disease therapy from traditional Chinese medicine. Biomed Res Int (2014) 0.77
In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine. Evid Based Complement Alternat Med (2014) 0.75
Susceptible gene of stasis-stagnation constitution from genome-wide association study related to cardiovascular disturbance and possible regulated traditional Chinese medicine. BMC Complement Altern Med (2015) 0.75
In silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers. Biomed Res Int (2014) 0.75
Design of glucagon-like Peptide-1 receptor agonist for diabetes mellitus from traditional chinese medicine. Evid Based Complement Alternat Med (2014) 0.75
Lead discovery for Alzheimer's disease related target protein RbAp48 from traditional Chinese medicine. Biomed Res Int (2014) 0.75
Ligand-based and structure-based investigation for Alzheimer's disease from traditional chinese medicine. Evid Based Complement Alternat Med (2014) 0.75
An investigation of small GTPases in relation to liver tumorigenesis using traditional Chinese medicine. Biomed Res Int (2014) 0.75
Finding inhibitors of mutant superoxide dismutase-1 for amyotrophic lateral sclerosis therapy from traditional chinese medicine. Evid Based Complement Alternat Med (2014) 0.75
The inhibition of folylpolyglutamate synthetase (folC) in the prevention of drug resistance in Mycobacterium tuberculosis by traditional Chinese medicine. Biomed Res Int (2014) 0.75
Insight into HIV of IFN-induced myxovirus resistance 2 (MX2) expressed by traditional Chinese medicine. Biomed Res Int (2014) 0.75
Possible inhibitor from traditional Chinese medicine for the β form of calcium-dependent protein kinase type II in the treatment of major depressive disorder. Biomed Res Int (2014) 0.75
Investigation of estrogen receptor (ESR1) for breast cancer from traditional Chinese medicine. Biomed Res Int (2014) 0.75
In Silico Investigation of Cytochrome P450 2C9 in relation to Aging Using Traditional Chinese Medicine. Evid Based Complement Alternat Med (2014) 0.75
Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer. Biomed Res Int (2014) 0.75
Lead screening for CXCR4 of the human HIV infection receptor inhibited by traditional Chinese medicine. Biomed Res Int (2014) 0.75
In Silico Insight into Potent of Anthocyanin Regulation of FKBP52 to Prevent Alzheimer's Disease. Evid Based Complement Alternat Med (2014) 0.75
Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine. Evid Based Complement Alternat Med (2014) 0.75
Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancers. Biomed Res Int (2014) 0.75
Lead Screening for HIV of C-C Chemokine Receptor Type 5 Receptor Inhibited by Traditional Chinese Medicine. Evid Based Complement Alternat Med (2014) 0.75
In silico design of BACE1 inhibitor for Alzheimer's disease by traditional Chinese medicine. Biomed Res Int (2014) 0.75
Drug design for neuropathic pain regulation from traditional Chinese medicine. Sci Rep (2013) 1.30
Developing hypothetical inhibition mechanism of novel urea transporter B inhibitor. Sci Rep (2014) 0.78
Residue-based design of small molecule inhibitor for H1N1, H5N1 and H7N1 mutants. J Mol Model (2015) 0.75